21 results on '"Retel, V.P."'
Search Results
2. Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis
3. Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands
4. Patient access to voice prostheses and heat and moisture exchangers: Factors influencing physician’s prescription and reimbursement in eight European countries
5. Prospective cost-effectiveness analysis of genomic profiling in breast cancer
6. 164P Early evaluation of effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer
7. 1694MO Socio-economic consequences among adolescent and young adult cancer patients: A European perspective
8. PCN377 WHERE DO WE GO WITH WHOLE GENOME SEQUENCING IN ONCOLOGY? USING SCENARIO DRAFTING TO EXPLORE FUTURE DEVELOPMENTS
9. PCN324 PRELIMINARY EVIDENCE SUGGESTS THAT WE MOVE TOWARDS THE USE OF LIQUID BIOPSIES TO PREDICT RESPONSE TO TKI INHIBITORS: A SYSTEMATIC REVIEW
10. PCN77 COST-UTILITY, COST-EFFECTIVENESS, AND BUDGET IMPACT OF INTERNET-BASED COGNITIVE BEHAVIOURAL THERAPY FOR BREAST CANCER SURVIVORS WITH TREATMENT-INDUCED MENOPAUSAL SYMPTOMS
11. PPM6 USING SCENARIO DRAFTING TO EVALUATE AND FACILITATE FUTURE ADOPTION OF TUMOR-INFILTRATING LYMPHOCYTES (TIL) THERAPY IN ADVANCED MELANOMA
12. PMD25 FACTORS INFLUENCING PHYSICIAN'S PRESCRIPTION AND REIMBURSEMENT OF MEDICAL DEVICES USED IN LARYNGECTOMY REHABILITATION IN EUROPE
13. CN3 - Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy
14. PCN214 - Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing
15. PCN170 - Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer
16. PCN149 - Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients
17. PD-0371: Comparative cost / QALY of guideline-recommended prostate cancertreatments: a UK cost perspective
18. 207 70-Gene Signature Prospectively Predicts Prognosis of Patients with Node-negative Breast Cancer: 5 Year Follow-up of the RASTER Study
19. 529 Cost-effectiveness and budget impact of the 70-gene signature for node-negative breast cancer
20. 0241 Scenarios as a tool for decision making in case of the 70-gene signature for breast cancer patients
21. 8119 POSTER Photodynamic Therapy, a new treatment modality in head and neck cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.